Novartis (NVS): forecast and analysis
Updated automatically · prices as of 2026-11-08
price over the last 6 monthsmost likely in 1 monthdark band: the price ends there 1 time in 2light band: 8 times in 10
54 chances in 100 of ending higher in a month, according to the AI. Low confidence: in cases like this the AI is often wrong. Look mainly at the expected volatility. Real reliability: on years it never saw, the AI got the direction right 56 times in 100 (always giving the same answer: 55).
Summary
For the coming month, the radar sees Novartis slightly higher (low confidence: the AIs are often wrong in such cases). Central scenario: about $164.17. In 8 cases out of 10, the price should stay between $148.72 and $177.20. Probability of beating world stocks outside the US over the same period: 52%.
Expected movement next month: about ±7%, up or down.
Confident call Next month, Novartis should be clearly calmer than in recent weeks (about 15% less). When the AI is this clear-cut, it was right 79 times out of 100 on years it had never seen.
Volatility over the last 20 sessionsAI forecast (next month)Its one-year normal
The AI's past calls on this asset
3 calls recorded, being checked (20 sessions). All checked calls
Open the interactive chart and simulator
Key indicators
| RSI (14) | 65 |
| ADX (trend strength) | 27 |
| Expected move over the next 5 sessions | ±4.1% |
| 3-month performance | +3.7% |
| Annualised volatility | +29% |
| Risk level | Medium |
Levels to watch
| Resistance (1-year high) | $164.98 |
| 50-day moving average | $148.83 |
| 200-day moving average | $151.50 |
| Support (20-day low) | $142.31 |
| Indicative stop-loss | $155.70 |
Reliability
Measured accuracy of the model on periods it never saw: 56% correct directions (naive baseline 55%). A forecast is a probability, never a promise.